Key result
Cytokines trigger variable adhesion molecule activation across endothelial lines through mechanisms independent of NF-kappa B.
Answers are grounded in this paper and cite their sources.
It is well accepted that the induction of endothelial cell (EC) adhesion molecules is a critical component in acute inflammatory responses as well as allogeneic interactions in vascularized allografts and, possibly, atherogenesis. The "inflammatory triad" of interleukin 1 (IL-1), tumor necrosis factor, and lipopolysaccharide are potent stimulators of the EC activation/adhesion molecules intercellular adhesion molecule 1 (ICAM-1), endothelial-leukocyte adhesion molecule 1 (ELAM-1), and vascular cell adhesion molecule 1 (VCAM-1). To address whether there exist differing thresholds to cytokine-mediated EC activation, we utilized a panel of genetically distinct human umbilical vein EC lines, assessing their modulated EC surface expression and transcriptional responses to cytokines, with regard to the cell adhesion molecules (CAMs) ELAM-1, ICAM-1, and VCAM-1. With submaximal concentrations of cytokine, EC ELAM-1 surface expression varied from negligible to marked. This phenotypic response was maintained over numerous passages in culture and was observed in ex vivo organ culture analyses with cytokine-treated umbilical vein sections. Relative patterns of ELAM-1, ICAM-1, and VCAM-1 induction were similar in response to multiple stimuli (IL-1, tumor necrosis factor, and lipopolysaccharide, but not phorbol 12-myristate 13-acetate). Nuclear run-off experiments demonstrated that the "high responder" phenotype is a consequence of enhanced transcriptional activation of the CAM genes in response to IL-1 (1 unit/ml), whereas transcriptional responses in "low responders" are minimal. Despite the known involvement of NF-kappa B in endothelial CAM transcription, gel shift assays failed to demonstrate a correlation between the levels of IL-1-mediated nuclear NF-kappa B expression and CAM induction in high and low responding lines. We postulate that varying EC activation thresholds to cytokines observed here, in vitro, may be a critical determinant in the susceptibility to vasculopathic states.
No takes yet. Share an insight, caveat, or question.
Bender et al. (1994) studied Endothelial cell activation and susceptibility to vasculopathic states. Cytokine stimulation (interleukin 1, tumor necrosis factor, and lipopolysaccharide) vs. Phorbol 12-myristate 13-acetate or low responder endothelial cell lines was evaluated on Endothelial cell surface expression and transcriptional activation of cell adhesion molecules (ELAM-1, ICAM-1, and VCAM-1). Cytokine stimulation induced varied ELAM-1, ICAM-1, and VCAM-1 transcriptional activation across genetically distinct endothelial cell lines, independent of NF-kappa B.
Synapse has enriched 10 related papers. Consider them for comparative context: